Gilead Sciences, Inc.
Pyrrolo[1,2-b]pyridazine derivatives
Last updated:
Abstract:
A compound of Formula (I): ##STR00001## pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed.
Status:
Grant
Type:
Utility
Filling date:
9 Aug 2019
Issue date:
6 Jul 2021